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Summary
Chronic exposure to nicotine elicits upregulation of
high-affinity nicotinic receptors in the smoker’s brain.
To address the molecular mechanism of upregulation,
we transfected HEK293 cells with human 42 recep-
tors and traced the subunits throughout their intra-
cellular biosynthesis, using metabolic labeling and
immunoprecipitation techniques. We show that high-
mannose glycosylated subunits mature and assem-
ble into pentamers in the endoplasmic reticulum and
that only pentameric receptors reach the cell surface
following carbohydrate processing. Nicotine is shown
to act inside the cell and to increase the amount of
 subunits immunoprecipitated by the conformation-
dependent mAb290, indicating that nicotine enhances
a critical step in the intracellular maturation of these
receptors. This effect, which also takes place at con-
centrations of nicotine found in the blood of smokers
upon expression of 42 in SH-SY5Y neuroblastoma
cells, may play a crucial role in nicotine addiction and
possibly implement a model of neural plasticity.
Introduction
In addition to their direct pharmacological action on
their specific receptors, many drugs of abuse elicit cel-
lular adaptation following prolonged exposure. These
plasticity phenomena described for several G protein-
coupled receptors, including the opioid receptor, typi-
cally result in receptor internalization followed by
downregulation (Roth et al., 1998). In this context, the
case of nicotinic acetylcholine receptors (nAChRs) is
rather unusual, since long-term exposure to nicotine
elicits receptor upregulation in the smoker’s brain (Ben-
well et al., 1988) and in rodent brain (Marks et al., 1983;
Schwartz and Kellar, 1983) as well as in cell lines ex-
pressing various neuronal nAChRs (Peng et al., 1997;
Whiteaker et al., 1998). Upregulation, which corres-
ponds to an increase in high-affinity binding sites for
nicotine, in general produces potentiation of the nico-
tinic response, particularly in cell lines (Buisson and*Correspondence: changeux@pasteur.fr (J.-P.C.); pjcorrin@pasteur.
fr (P.J.C.)Bertrand, 2001; Gopalakrishnan et al., 1996) and in
brain synaptosomes (Nguyen et al., 2004; Rowell and
Wonnacott, 1990).
The neuronal nAChRs subject to upregulation are
pseudosymmetrical heteropentameric ion channels re-
sulting from the assembly of principal (α2, α3, α4, α6)
and complementary (β2, β4) subunits. At the concentra-
tions of nicotine found in the brain of smokers (low
micromolar range), the highly expressed α4β2 recep-
tors display the highest level of upregulation (Nguyen
et al., 2003). Since receptors containing the β2 subunits
are the most important for nicotine self-administration
in mice (Picciotto et al., 1998), it is likely that their
upregulation contributes to the long-term effect of
chronic nicotine and potentially to nicotine addiction
(Buisson and Bertrand, 2002). Along with other factors,
upregulation may contribute to nicotine sensitization,
since both phenomena take place with similar kinetics
(Marks et al., 1983).
Since nicotine is known to penetrate the cell mem-
brane (Whiteaker et al., 1998), the localization of its site
of action for upregulation, inside the cell or at the cell
surface, remains a debated issue. In previous work
(Sallette et al., 2004), we identified a protein microdo-
main that controls the differences of upregulation no-
ticed between β2 and β4 containing receptors. This
microdomain is located at the subunit interface, in
close contact with the ligand binding site. In spite of
this molecular identification, little is known about the
cellular mechanisms underlying nicotine upregulation.
In vivo studies in both rodents and cell lines have
shown no change in mRNA levels following upregula-
tion, pointing to a posttranscriptional effect of nicotine.
Many studies were attempted to elucidate the mecha-
nisms by which nicotine upregulates various combina-
tions of nAChRs reconstituted in cell lines and in the
Xenopus oocytes, leading to a wide range of hypothe-
ses, in particular: (1) a role of nAChR desensitization
(Fenster et al., 1999), (2) a decrease of the turnover rate
of already assembled surface receptors (Peng et al.,
1994), followed by an increased internalization of the
receptors (Peng et al., 1997), (3) a maturational role of
nicotine that promotes subunit assembly (Wang et al.,
1998), or (4) an isomerization of low-affinity surface re-
ceptors into high-affinity receptors (Buisson and Ber-
trand, 2002).
In order to elucidate at which step nicotine acts, we
studied the maturation and trafficking of human α4β2
nAChRs expressed in HEK293 cells using pulse-chase
metabolic labeling, subunit-specific immunoprecipita-
tion, and glycosydases digestions. Our results show
that nicotine acts intracellularly on early maturational
steps of ER-located species. A similar intracellular ef-
fect of nicotine on early maturational steps is also ob-
served in α4β2 transfected SH-SY5Y human neuro-
blastoma cells at concentrations of nicotine found in the
blood of smokers, further supporting that this mechanism
contributes to nAChR upregulation in smokers.
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Figure 1. Subunit Processing within HEK293 Cells E
(A) Specificity of mAb299 and mAb290 antibodies. (Upper panel) n
α4 or β2 transfected cells metabolically labeled for 3 hr and immu- u
noprecipitated with mAb299 or mAb290 as indicated, fractionated b
on a 7% SDS-polyacrylamide gel, and visualized by autoradiogra-
cphy. (Lower panel) Similar experiments on nontransfected (NT) and
α4β2 transfected cells, in control (without nicotine) or 1 mM nico-
tine conditions (+Nic).
(B) Glycosylation state of the α4m, α4c, β2m, and β2c species.
pControl (−Nic) or 1 mM nicotine upregulated (+Nic) α4β2 trans-
dfected cells metabolically labeled for 30 min and chased for 6 hr
((lanes d–f) or not (lanes a–c), followed by mAb290 immunoprecipi-
ttation, digestion by Endoglycosydase-H (lanes b and e) or by
GPNGase-F (lanes c and f), running on 7% SDS-polyacrylamide gel
land visualization by autoradiography. (Right panel) Surface recep-
ptors of α4β2 transfected cells upregulated with 1 mM nicotine were
olabeled with sulfo-NHS-biotine, immunoprecipitated by mAb290,
cdigested by Endoglycosydase-H or by PNGase-F, run on 7% SDS-hase, α4c and β2c bands are in addition present (lane
olyacrylamide gel, and visualized by immunoblotting with peroxy-
ase-conjugated extravidine.
C) immunofluorescence imaging in HEK293 cells. Images show a
ypical HEK cell transfected with α4, β2, and pECFP-Golgi. The
olgi apparatus was visualized by the cyan fluorescence (upper
eft panel), the β2 subunits by the red fluorescence (upper right
anel), and the ER by the green fluorescence (lower left panel). The
verlay of the three colors in the lower right panel shows strong
olocalization between β2 and the ER (yellow color).esults
nti-4 mAb299 and anti-2 mAb290 Antibodies
isplay Different Patterns of Subunit Recognition
e expressed the human α4 and β2 subunits by tran-
ient transfection in HEK293 cells followed by meta-
olic labeling. nAChRs were then solubilized with a
ixture of lubrol/phosphatidylcholine (Green and Clau-
io, 1993) and immunoprecipitated with the commer-
ially available anti-α4 mAb299 and anti-β2 mAb290
ntibodies (Lindstrom, 1996; Whiting and Lindstrom,
988). We confirmed their high specificity, but also re-
ealed unexpected patterns of subunit recognition (Fig-
re 1A).
First, mAb299 immunoprecipitated the α4 subunit
ither when α4 was expressed alone or when ex-
ressed together with the β2 subunit. In contrast,
Ab290 recognized the β2 subunit only when β2 was
xpressed with the α4 subunit. In this latter condition,
fficient coimmunoprecipitation was observed between
4 and β2, indicating that hetero-oligomerization had
ccurred after 3 hr of metabolic labeling. Thus, hetero-
ligomerization of β2 with α4 is required for the interac-
ion of mAb290 with β2, but not for the interaction of
Ab299 with α4.
Second, with α4β2 transfected cells, the α4 and β2
ubunit coimmunoprecipitated by mAb290 appeared
oth as double bands, with the major bands corre-
ponding to those immunoprecipitated by mAb299
called α4m and β2m, respectively), and minor bands of
lightly higher molecular weight (called α4c and β2c,
espectively). The apparent molecular weights for α4m,
2m, α4c, and β2c estimated on gels were 70, 51, 74,
nd 54 kDa, respectively.
omplex Oligosaccharide Glycosylation and Surface
xport of the 42 Receptors
e then tested the possibility that the different migra-
ion profiles correspond to different glycosylation
tates of the α4 and β2 subunits. Since different glyco-
ylation states typically appear sequentially in the
ourse of the maturation process, we metabolically la-
eled α4β2 transfected cells for 30 min, followed by a
hase period of either 0 or 6 hr. After immunoprecip-
tation by mAb290, we performed digestions with
NGase-F, which reacts with glycoproteins by eliminat-
ng all carbohydrates from N-linked glycosylations, and
ndo-H, which reacts with proteins carrying high-man-
ose carbohydrates (Kornfeld and Kornfeld, 1985). Fig-
re 1B shows that at 0 hr chase, only α4m and β2m
ands are immunoprecipitated (lane a), whereas at 6 hr
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597d) and correspond to approximatively 40% of the im-
munoprecipitated material. This suggests that the α4m
and β2m bands are converted into the α4c and β2c
bands in the course of subunit processing.
At 0 hr chase, the digestion profiles of α4m and β2m
by Endo-H and PNGase-F were similar (lanes b and c),
with a quantitative conversion into nonglycosylated
bands at apparent molecular weights of 64 and 46 kDa,
respectively, corresponding to fully deglycosylated
subunits, as verified by growing the cells in the pres-
ence of tunicamycine followed by immunoprecipitation
with mAb 290 (data not shown). These bands fitted rea-
sonably well with the calculated molecular weight from
the protein sequence, with 70 kDa for α4 (627 amino
acids) and 57 kDa for β2 (502 amino acids). This indi-
cates that these subunit species carry only high-man-
nose carbohydrates. After 6 hr chase, the α4c and β2c
bands were completely digested by PNGase-F (lane f),
but partially resistant to Endo-H treatment (lane e), with
intermediate apparent molecular weights of 71 and 50
kDa, respectively, thus showing that α4c and β2c bands
carry a mixture of high mannose and complex type car-
bohydrates.
The protein sequences of α4 and β2 reveal, respec-
tively, three (at positions 38, 88, and 155) and two (at
position 33 and 150) putative N-glycosylation sites
(Monteggia et al., 1995). Interestingly, Endo-H treat-
ment reduced the apparent molecular weight by 3–4
kDa on both α4c and β2c, and PNGase-F removed 10
and 8 kDa, respectively, suggesting that one putative
glycosylation site in both α4 and β2 remains of the
high-mannose type, the remaining two (for α4) and one
(for β2) being further processed to complex carbohy-
drate.
These observations suggest that the α4m and β2m
correspond to subunits located in the proximal secre-
tory pathway, from the ER to medial Golgi, while α4c
and β2c have escaped from these compartments and
have undergone trimming and complex oligosaccha-
ride glycosylations in the medial-Golgi. Such a scheme
predicts that surface α4β2 should be composed only of
α4c and β2c subunits. To test this possibility, we specifi-
cally labeled surface receptors by subjecting the α4β2
transected cells to a membrane impermeant biotinyla-
tion reagent (sulfo-NHS-biotine), followed by an immu-
noprecipitation with mAb290 and immunoblotting with
peroxydase-conjugated extravidine. Differential diges-
tion by Endo-H (Figure 1B) or by PNGase-F showed
that the entire population of surface nAChRs is made
of partially Endo-H-resistant subunits.
To investigate the cellular location of the β2 subunits
within the cells, we performed immunofluorescence im-
aging experiments. HEK293 cells were transfected with
the α4 and β2 subunits, along with a pECFP-Golgi pro-
tein, which contains the targeting sequence from hu-
man β1,4-galactosyltransferase. After fixation of the
cells, the β2 subunit was labeled by mAb290, and the
ER-associated protein disulfide isomerase was labeled
using a primary antibody. Figure 1C shows that the ma-
jority of the β2 subunits colocalized with the ER marker,
whereas no or weak colocalization was observed with
the Golgi protein. These data show that the majority of
β2 subunits are distributed within the ER.
Altogether, our data indicate that within 30 min aftermetabolic labeling, subunits are present in their high-
mannose form and are thus probably located in the ER.
Efficient coimmunoprecipitation between α4 and β2 is
already observed at this stage, pointing to the presence
of hetero-oligomers. At 6 hr chase, a significant fraction
of subunits carrying complex oligosaccharides is pre-
sent in the whole-cell population, suggesting that they
belong to receptors that have escaped the ER and have
been processed in the Golgi apparatus. Only subunits
carrying complex oligosaccharides are found at the
cell surface.
Pentameric Assembly Is Required for Receptor
Complex Glycosylations and Surface Export
Sedimentation analysis of nonradioactive lubrol/phos-
phatidylcholine-solubilized α4β2 receptors followed by
measurement of [3H]-epibatidine binding on each frac-
tion of the gradient (Figure 2A) shows the species dis-
playing high affinity for [3H]-epibatidine sediment as a
peak that corresponds to pentameric receptor, as pre-
viously reported for Triton X-100 solubilized human
α4β2 receptors (Nelson et al., 2003). However, in con-
trast to Triton X-100 solubilized receptors that give a
narrow peak (confirmed in the present study, data not
shown), the decrease of this peak at the high sedi-
mentation coefficients is relatively slow, indicating that
higher molecular weight species potentially also bind
[3H]-epibatidine.
The oligomeric distribution of the different glycosyla-
tion states of α4 and β2 subunits was assessed by met-
abolically labeling α4β2 cells for 3 hr and immunopreci-
pitating each fraction of the gradient with mAb290.
Figure 2B shows that α4c and β2c both exhibited a sin-
gle peak centered at the pentamer level, whereas α4m
and β2m species were more widely distributed, with
around 60% of the total amount of each subunit sedi-
menting at a peak corresponding to the pentameric
form. The remaining 40% were spread in all the frac-
tions corresponding to higher sedimentation coeffi-
cients, indicating the presence of a heterogeneous
population of oligomers containing more than five sub-
units.
These results show that subunit pentamerization oc-
curs before carbohydrate trimming and processing,
most probably within the ER. The higher-order oligomer
population found in the ER appeared heterogeneous,
but at least a subpopulation bound [3H]-epibatidine
with high affinity. These species may constitute either
intermediate oligomers in the course of the maturation
process, incorrectly assembled oligomers that would
no longer give rise to mature receptors and be eventu-
ally degraded, or small aggregates resulting from pro-
longed solubilization in lubrol/phosphatidylcholine. In
this latter case, it is noteworthy that such species are
not observed for subunits harboring complex oligosac-
charides, indicating that such aggregation would in-
volve relatively immature subunits. Interestingly, sub-
units harboring complex oligosaccharides were only
integrated in pentameric receptors, suggesting that
correct pentamerization is a requirement to escape the
quality control of the ER.
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tFigure 2. Nature of the Oligomeric Species in HEK293 Cells
t(A) Solubilized receptors from α4β2 transfected cells were run on a
t3%–30% sucrose gradient, and [3H]-epibatidine binding was mea-
dsured for each fraction.
0(B and C) Control (panel B) or 1 mM nicotine upregulated (panel C)
α4β2 transfected cells metabolically labeled for 3 hr, solubilized, n
and ran on a 3%–30% sucrose gradient. Each fraction was immu- β
noprecipitated by mAb290 and fractionated on 7% SDS-polyacryl- c
amide gel. For each gradient, the bottom panel shows the gels
avisualized by autoradiography, and the upper panel shows its
mquantification by scanning densitometry. α4 and β2 species are
represented by gray squares and black diamonds, respectively,
whereas high-mannose and complex oligosaccharide carrying spe- a
cies are drawn with full and dashed lines, respectively. i
i
n
Upregulation by Nicotine: Parallel Increase in High- b
Affinity Binding Site and in Immunoprecipitation b
of the Different Subunit Species t
As a next step, we investigated the effect of chronic w
nicotine on these cellular processes. When cells are (
grown for 24 hr in the presence of 1 mM nicotine, n
upregulation (measured as the increase of the number n
of high-affinity binding sites for the agonist [3H]-epibati- p
dine as compared to control condition without nicotine) m
was concentration dependent (Figure 3A) with a sig- t
moid shape (EC50 around 0.1 M, Hill number [nH] = 1) r
and a maximal upregulation of 2.44 ± 0.11-fold. When d
scells were cultured for only 3 hr in the presence of nico-ine, a procedure that more closely replicates immuno-
recipitation experiments (see below), the concentration-
ependence curve shifted to higher concentrations, with
n EC50 around 1 M (nH = 1) but a comparable maxi-
al amplitude (2.05 ± 0.25-fold). This indicates that,
ithin 3 hr, the steady state of upregulation is not
eached at submaximal concentrations. Finally, we
valuated the fraction of surface versus intracellular
umber of binding sites by taking advantage of the high
embrane permeability for epibatidine and of the
embrane impermeability of the agonist carbamylcho-
ine during the 30 min binding assay (Whiteaker et al.,
998). Figure 3A# shows that, in control and upregu-
ated conditions, carbamylcholine displaced 13.4% ±
.2% and 19.7% ± 7.0% of the [3H]-epibatidine binding
ites, respectively, indicating that (1) around 85% of the
ites were not accessible to carbamylcholine and were
herefore intracellular in both conditions and that (2) ni-
otine did not dramatically change the proportion of
urface versus intracellular binding sites.
The changes in the amount of immunoprecipitated
ubunits associated to “upregulation in binding” was
ssessed by performing mAb299 or mAb290 immuno-
recipitations of solubilized nAChRs from cells upregu-
ated by increasing concentrations of nicotine. In all the
ollowing immunoprecipitation experiments, nicotine
nd nicotinic ligands were added to the culture medium
4 hr before metabolic labeling and remained at the
ame concentration during methionine deprivation,
etabolic labeling, and chase step. In the present ex-
eriments, we selected a 3 hr metabolic labeling with
o chase period. A roughly linear concentration-depen-
ent increase in the amount of immunoprecipitated
ubunits was observed with both antibodies (Figures
B and 3C), as a function of log([nicotine]), independent
f the antibody used or the species considered. In par-
icular, no significant change was observed upon nico-
ine treatment in (1) coimmunoprecipitation, since both
he α4m/β2m and α4c/β2c ratios remained stable at the
ifferent concentrations of nicotine (0.61 ± 0.07 and
.99 ± 0.18 for α4m/β2m in mAb290 and mAb299 immu-
oprecipitations, respectively, and 0.54 ± 0.11 for α4c/
2c in mAb290 immunoprecipitation) or (2) complex gly-
osylated versus high-mannose subunits (0.50 ± 0.06
nd 0.44 ± 0.07 for β2c/β2m and α4c/α4m, respectively, in
Ab290 immunoprecipitation experiments, Figure 3B#).
Therefore, upregulation in binding, corresponding to
n increased number of oligomers displaying high affin-
ty for epibatidine, is concomitant to an “upregulation
n immunoprecipitation,” corresponding to an increased
umber of α4β2 hetero-oligomers immunoprecipitated
y both mAb290 and mAb299. It is noteworthy that
oth processes are observable at a nicotine concentra-
ion as low as 10 nM. However, significant differences
ere found in the concentration-dependence curves:
1) the increase in binding site was maximal at 10 M
icotine concentration, whereas the amount of immu-
oprecipitated subunits continued to increase in an ap-
arent linear manner at 100 M and 1 mM; (2) the maxi-
al increase in binding sites was 2.5-fold, as compared
o the increase in subunit immunoprecipitation that
eached 3- to 4-fold. These differences are probably
ue to the fact that different populations of receptor
ubunits are observed in both experiments: binding
Upregulation of Neuronal Nicotinic Receptors
599Figure 3. Pharmacology of Upregulation in Binding and in Immuno-
precipitation in HEK293 Cells
(A) [3H]-epibatidine binding dose upregulation curve after 3 (gray)
and 24 hr (black) nicotine incubation. The percentage of intracel-
lular versus surface binding sites in upregulated and control con-
ditions, evaluated using carbamylcholine competition (at 1 mM
during 30 min), is shown in (A#). Points are the mean of three exper-
iments, and error bars represent standard deviation.
(B and C) Dose upregulation curves performed using α4β2 trans-
fected cells metabolically labeled for 3 hr, immunoprecipitated by
mAb290 (B) or mAb299 (C), and fractionated on 7% SDS-polyupregulated by nicotine, we subjected 1 mM nicotine
acrylamide gel. For each experiment, the bottom panel shows the
gel visualized by autoradiography, and the upper panel shows its
quantification by scanning densitometry. α4 and β2 species are
represented by gray squares and black diamonds respectively,
whereas high-mannose and complex oligosaccharide carrying spe-
cies are drawn with full and dashed lines, respectively. The global
mean ratio of complex versus high-mannose carbohydrate carrying
subunits ratios for α4 (gray) and β2 (black) is shown in (B#).
(D) α4β2 transfected cells were upregulated by either 1 mM nico-
tine, 1 mM carbamylcholine, 100 M DHβE, or 1 mM choline. These
compounds were continuously present during a 24 hr period in the
culture medium and during the following 30 min of metabolic label-
ing and 45 min of chase. Receptors were immunoprecipitated by
mAb290 and visualized by autoradiography (lower panel) followed
by quantification by scanning densitometry (gray bars in the upper
panel, which represent the increase in the α4 band intensity as
compared to control conditions). In parallel, the upregulation ratios
of the [3H]-epibatidine binding sites were measured on cells upreg-
ulated under the same conditions (black bars, which represent the
mean of three independent experiments, error bars represent stan-
dard deviation.).studies measure the entire receptor population present
in the cells, whereas immunoprecipitation experiments
reveal only subunits that have been synthesized during
the 3 hr of metabolic labeling.
Upregulation Is Concomitant with a Functional
Potentiation of the Electrophysiological Response
We recorded the electrophysiological response of α4β2
transfected HEK293 cells when cells were grown in
control medium or after 24 hr upregulation by 1 M and
1 mM nicotine. Figure 4 shows typical current traces
when receptors were rinsed for 1 hr with nicotine-free
medium and then activated by two concentrations of
ACh, one below its EC50 (at 30 M) and one at a satu-
rating concentration (1 mM). Activation by 1 mM ACh
illustrates that prolonged exposure of nicotine at 1 M
and 1 mM induces a potentiation of the response,
which reaches respectively 1.5- and 1.7-fold (Figure
4B). The potentiation is associated with significant
changes in the receptor properties: (1) the ratio I(30
M)/I(1 mM) increased from 0.30 to 0.38 and 0.39 in
control, 1 M and 1 mM upregulated conditions, re-
spectively, indicating a change in ACh EC50 (Figure 4B);
(2) upregulated receptors display significantly slower
desensitization kinetics. Fitting the desensitization
component of the traces with a monoexponential
yielded time constants of 430 ± 80 and 900 ± 200 ms for
control and 1 mM upregulated conditions, respectively.
Thus, upregulated receptors are functional, since the
ratio of upregulation in binding (2.4-fold) and of func-
tional potentiation in electrophysiology (1.7-fold) are
comparable. Moreover, the functional potentiation is
associated with a decreased EC50 for ACh and slower
desensitization kinetics, as previously described for hu-
man α4β2 receptors stably expressed in HEK293 cells
(Buisson and Bertrand, 2001).
Nicotine Upregulation in Immunoprecipitation
Occurs Intracellularly on High-Mannose
Glycosylated Subunits
To investigate in more detail which subunit species are
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(A) typical trace currents evoked by a 3s application of ACh at 30 b
M (gray traces) and 1 mM (black traces) on α4β2 transfected cells t
in control condition and after 24 hr upregulation by 1 M and 1 mM c
nicotine. Note that the kinetics of desensitization is decreased in
pupregulated conditions.
n(B) Mean currents evoked by these ACh concentrations in control,
c1 M, and 1 mM nicotine upregulated cells (each value represents
the mean of 13 cells, error bars represent standard error of mean), c
illustrating the functional potentiation of 1 mM ACh-evoked cur- d
rents and that 30 M ACh-evoked currents are more potentiated
than 1 mM ACh-evoked currents, indicative of a decrease of the DACh EC50.
a
T
oupregulated α4β2 expressing cells to immunoprecipita-
tion experiments, followed either by digestions with gly- f
bcosidases or sucrose gradient sedimentation analysis.
Figure 1B shows that similar patterns of Endo-H/
mPNGase-F digestion were observed between control
and upregulated cells (lanes b and c). After 30 min met- e
aabolic labeling with no chase period, no complex glyco-
sylated bands were formed, and nicotine increased the s
camount of high-mannose subunits by about 3-fold. At
the 6 hr chase period (lane d), high-mannose and com- a
tplex oligosaccharide subunits were increased in a sim-
ilar manner by nicotine treatment, suggesting that 3
mnicotine did not significantly alter the subsequent pro-
cesses of trimming and complex oligosaccharide gly- c
scosylations.
Sucrose gradient analysis revealed that the oligo- h
cmeric distribution is not qualitatively altered by the
presence of chronic nicotine (Figure 2C). The subunits b
carrying complex oligosaccharides remained com-
pletely associated in pentamers, and the ratio of penta- o
(meric versus higher oligomeric states was not signifi-
cantly changed for the high-mannose population. b
cNicotine action resulted in a global increase (around
3-fold) in the amount of immunoprecipitated proteins, t
tregardless of the type of oligomer.
Altogether, the main consequence of chronic nicotine 5
ais to increase the intensity of the high-mannose bands
as early as 30 min after protein synthesis, thus provid- c
ding an unambiguous demonstration of an intracellularction of nicotine on the early step of subunit matu-
ation.
harmacology of Upregulation
f Immunoprecipitated Material
e tested the agonists nicotine (1 M) and carba-
ylcholine (1 mM) and the antagonist dihydro-β-eryth-
oïdine DHβE (100 M)—all reported to elicit upregula-
ion—and choline (1 mM), which is the precursor in the
iosynthesis of acetylcholine. Figure 3D shows that a
ood correlation exists between upregulation in bind-
ng sites and in immunoprecipitation by mAb290 of the
igh-mannose species: 3.5 and 3.2 for nicotine upregu-
ation in binding sites and immunoprecipitation, respec-
ively, 2.7 and 3.3 for carbamylcholine, 3.1 and 3.3 for
HβE, and 2.1 and 2.6 for choline. It is noteworthy that
he compounds were in all cases added to the culture
edium 24 hr before performing the metabolic labeling
30 min) and the chase (45 min). This procedure was
elected in order to optimize the intensity of the sub-
nits carrying high-mannose carbohydrates as com-
ared to those carrying complex carbohydrates (see
elow). These data demonstrate that the various nico-
inic effectors tested produce upregulation by an intra-
ellular action. Therefore, even the weakly membrane-
ermeable compound carbamylcholine, which does
ot enter the cell to significant extent during the 30 min
urrently used for binding experiments, does enter the
ell after 24 hr incubation to a sufficient extent to pro-
uce intracellular upregulation.
ynamic Study of Nicotine Upregulation Reveals
n Effect on the Early Steps of Subunit Maturation
ime-resolved investigation of chronic nicotine action
n the different stages of subunit processing was per-
ormed by pulse-chase experiments after 30 min meta-
olic labeling (Figure 5).
In control condition, the high-mannose bands were
ost intense at 0 hr chase and decreased with appar-
nt half-life times (t1/2) around 8 and 6 hr in mAb290
nd mAb299 immunoprecipitation experiments, re-
pectively (Figures 5A and 5C). The subunits carrying
omplex oligosaccharides were absent at no chase, as
lready observed (Figure 1B). mAb290 immunoprecipi-
ated increasing amounts of α4c and β2c during the first
hr chase, followed by a slow decrease. Assuming that
Ab290 recognized the high-mannose and complex
arbohydrate species with similar affinities, these data
uggest that around 60% of the α4m/β2m present at 0
r chase are converted into α4c/β2c species in the
ourse of subunit processing, the remaining subunits
eing degraded by the cellular machinery.
In 1 mM nicotine upregulated conditions, the level
f immunoprecipitated subunits was strongly increased
Figures 5B and 5D). At 0 hr chase, the high-mannose
ands were significantly upregulated as compared to
ontrol condition (Figures 5E, 5F, 5H, and 5I), and con-
inued to increase during the first 45 min of chase in
he case of mAb290 (50% increase) to reach 1.8/2.3 and
.3/3.4 upregulation of the α4m/β2m species in mAb299
nd mAb290 experiments, respectively. 45 min after
hase, all bands decreased following a biexponential
ecay with a main contribution (around 90%) of a half-
Upregulation of Neuronal Nicotinic Receptors
601Figure 5. Kinetics of Appearance and Turnover of the Different Species in HEK293 Cells
Control (A and C) or 1 mM nicotine upregulated (B and D) α4β2 transfected cells were labeled for 30 min, chased at various times, immuno-
precipitated with mAb299 or mAb290, run on 7% SDS-polyacrylamide gel, and visualized by autoradiography ([A] and [B] for mAb 299,
quantified in [E] and [H], and panel [C] and [D] for mAb290, the high-mannose bands being quantified in [F] and [I] and the complex oligosac-
charide carrying subunits being quantified in [G] and [J]). α4 and β2 species are represented by gray squares and black diamonds, respec-
tively. Experimental points were fitted by empirical multiexponentials (E–J). Panels (A)–(D) show a typical experiment, and panels (E)–(J)
represent the mean of three independent experiments, error bars represent standard deviation. (K and L) Pulse-chase experiments of the
mAb290 immunoprecipitated β2 subunit species (experimental points from panels [F], [G], [I], and [J]) and their fits according to the two-step
maturational model.time around 4 hr. The kinetics of formation and turn
over of α4c and β2c were not significantly altered, but
their amount was upregulated by around 3-fold as com-
pared to control conditions (Figures 5G and 5J).
Altogether, these data show a dramatic effect of nico-
tine on the early step of subunit maturation: (1) the in-
crease in mAb290 and mAb299 immunoprecipitation
was observed as soon as 0 hr chase, indicating an earlyaction during the 30 min of radioactive subunit synthe-
sis, and (2) the increase in subunit immunoprecipitation
elicited by nicotine 45 min after the end of radioactive
subunit synthesis indicated that at 0 chase a subpopu-
lation of the subunits were not immunoprecipitated by
mAb290 and that nicotine converted at least a fraction
of this subpopulation into a conformation compatible
with mAb290 recognition. Indeed, we showed that het-
Neuron
602ero-oligomerization of the β2 subunit was required for i
gmAb290 antibody recognition, indicating that newly
synthesized β2 subunits are not recognized by mAb290. c
pTo tentatively assess the contribution of the matura-
tional process in upregulation, we developed a simpli- (
wfied two-step sequential model presented in Figure 5.
It postulates that newly synthesized high-mannose β2 s
psubunits are in an immature conformation not recog-
nized by mAb290, called Mβ2−. In the course of matura- m
ction, Mβ2− are converted to Mβ2+ (high-mannose β2
recognized by mAb290) and then to C (complex carbo- c
ihydrate β2), according to first-order rate constants.
Each species is degradated according to first-order ki- u
inetics. During the 30 min of metabolic labeling, Mβ2−
species are synthesized according to a linear time func- f
vtion “at.” Fitting kinetic data (Figures 5K and 5L) ac-
cording to this model (described in the Supplemental e
uData available with this article online) yielded a reason-
able set of parameters: in both control and upregulated s
cconditions, the a, k23, kt1, kt2, and kt3 were identical and
equal to 2 × 10−1, 2.5 × 10−3, 5 × 10−2, 1.5 × 10−3, and t
d1.5 × 10−3 min−1, respectively. Only the k12 constant
changed, from 6 × 10−3 to 18 × 10−3 min−1, in control m
cand upregulated conditions, respectively. This illustrates
that a single change of the k12 constant, which repre- b
nsents the rate of conversion of Mβ2− into Mβ2+, is suffi-
cient to reasonably account for the effect of nicotine on (
fupregulation. Whereas maturation is clearly a multistep
process, the model states that nicotine promotes early- s
istep maturation of subunits that would otherwise be
degraded. s
f
sNicotine Promotes Intracellular Subunit Maturation
6in SH-SY5Y Neuroblastoma Cells
To investigate the contribution of this mechanism in
hneuronal cell lines, we used transiently transfected hu-
Hman α4β2 SH-SY5Y human neuroblastoma cells. These
ccells resemble human fetal sympathetic neurons grown
din primary culture and express mRNAs for α3, α5, α7,
tβ2, and β4 subunits (Lukas et al., 1993) and functional
α7 and α3 containing nAChRs, the latter receptors be-
ing strongly upregulated by chronic nicotine (Peng et D
al., 1997). We first tried to metabolically label and im-
munoprecipitate with mAb290 the endogenous β2 sub- M
Ounits from these cells, but found no specific bands, in-
dicating that the amount of endogenous β2 subunits n
uwere too low to be detected by this technique. We thus
transfected these cells with the α4 and β2 subunits h
iusing the calcium phosphate procedure. [3H]-epibati-
dine binding shows that nontransfected cells carry 3.2 c
c± 0.4 fmol/dish high-affinity binding sites, and this value
raises to 4.9 ± 2.0 and 25.0 ± 13 upon upregulation by 1 a
aM and 1 mM nicotine, respectively. Upon transfection,
high-affinity binding site increased, with 89.3 ± 8.0, i
m162.5 ± 5.2, and 271 ± 8.9 fmol/dish in control, 1 M
and 1 mM upregulated conditions, respectively. It is p
tnoteworthy that the transfected HEK293 cells express
around 10-fold more binding sites than transfected h
aSH-SY5Y.
In mAb290 immunoprecipitation experiments, meta- a
abolic labeling for 30 min followed by different chase
periods indicates that the processing of the α4 and β2
fsubunit were similar in SH-SY5Y and HEK 293 cells. At
0 hr chase, the α4 and β2 subunits were present onlyn their high-mannose form and were quantitatively di-
ested by EndoH and PNGase-F, whereas at 6 hr
hase, subunits carrying complex carbohydrates ap-
eared and were partially resistant to EndoH treatment
Figure 6A, upper panels). The apparent molecular
eight of all glycosylation states for both subunits were
imilar in SH-SY5Y and HEK293 cells. Pulse-chase ex-
eriments further showed that the kinetics of high-
annose species turnover were similar between both
ell lines (Figure 6A, lower panel). Incubation of the
ells with 1 M and 1 mM nicotine resulted in a strong
ncrease in the amount of immunoprecipitated sub-
nits. Because of the low level of transfected subunits
n the neuroblastoma cells, their quantification was dif-
icult, and the complex olisaccharide bands were barely
isible in some cases. To limit the variability between
xperimental points, green fluorescent protein was
sed as an internal standard for the transfection and
ample processing efficiency. Thus, in these pulse-
hase experiments, GFP was coexpressed along with
he α4 and β2 subunits, and proteins were indepen-
ently immunoprecipitated with the anti-GFP and
Ab290 antibodies before loading on the gel. Quantifi-
ation of the α4 and β2 bands normalized to the GFP
and clearly show that nicotine at 1 M and 1 mM sig-
ificantly upregulates the subunits at all chase times
Figure 6B, with upregulation ranging from 1.5- to 3.5-
old), especially at 0 and 45 min chase, where most
ubunits carry high-mannose carbohydrates. Finaly, we
nvestigated the cellular location of the transfected β2
ubunit within the SH-SY5Y neuroblastoma cells and
ound that they colocalize in majority with the ER, in a
imilar way to what is found in HEK293 cells (Figure
C).
These data show that the intracellular increase of the
igh-mannose species observed upon transfection in
EK293 cells also occurs in SH-SY5Y neuroblastoma
ells, at low micromolar concentrations of nicotine, in-
icating that similar mechanisms of upregulation are
aking place in both cell lines.
iscussion
aturation and Trafficking of 42 Receptors
ur results dissect some elementary steps of neuronal
icotinic receptor maturation and surface export. Sub-
nits are initially synthesized as core-glycosylated
igh-mannose glycoproteins. This type of carbohydrate
s known to be inserted cotraductionally and to be
haracteristic of peptides residing in the proximal se-
retory pathway, from the ER to medial Golgi (Ellgaard
nd Helenius, 2003). Within this compartment, the α4
nd β2 subunits rapidly hetero-oligomerize, a step dur-
ng which the β2 subunit undergoes a conformational
aturation that allows interaction with mAb290. These
rocesses result in the generation of a mixed popula-
ion of pentameric oligomers and of a heterogeneous
igher molecular weight oligomer population that prob-
bly corresponds either to misfolded entities or to small
ggregates formed from immature subunits (Cooper
nd Millar, 1997).
We also found that only pentameric receptors exit
rom these compartments, as observed for muscle-
type nAChRs (Smith et al., 1987). Pentameric receptors
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603Figure 6. Nicotine Upregulation in α4β2 Transfected SH-SY5Y Neuroblastoma Cell Lines
(A) (Upper panel) Control, 1 M, and 1 mM nicotine upregulated α4β2 transfected SH-SY5Y neuroblastoma cells were labeled for 30 min and
chased for 0 or 6 hr, followed by Endo-H or PNGaseF treatment, mAb290 immunoprecipitation, and 7% SDS-polyacrylamide gel. (Lower
panels) More resolved pulse-chase experiments on SH-SY5Y cells tranfected with both α4β2 and GFP, followed by immunoprecipitation with
mAb290 and anti-GFP and 10% SDS-polyacrylamide gel (shown is the portion of the gel where α4 and β2 migrate and the portion where GFP
[32 kD] migrates).
(B) Quantification of upregulation. For each line, the normalized expression, equal to the sum of the α4 and β2 bands intensity divided by the
GFP protein band intensity, was calculated. Each point represents the normalized upregulation, equal to the normalized expression in upregu-
lated condition divided by the normalized expression in control conditions. Points corresponding to long chase periods are not shown
because bands were too low to be quantified accurately.
(C) Immunofluorescence imaging in SH-SY5Y cells. Images show a typical cell transfected with α4, β2, and pECFP-Golgi. The Golgi apparatus
was visualized by the cyan fluorescence (left panel), the β2 subunits by the red fluorescence (middle left panel), and the ER by the green
fluorescence (middle right panel). The overlay of the three colors in the right panel shows strong colocalization between β2 and the ER
(yellow color).are then processed within the secretory pathway where
the subunits acquire Endo-H resistance, most likely
within the medial-Golgi, to eventually reach the cell
surface. This process takes around 3 hr, in agreement
with the average process time to produce high-affinity
surface muscle-type nAChRs (Merlie and Lindstrom,
1983). Partial EndoH resistance of α4c and β2c sug-
gested the presence of one high-mannose carbohy-
drate on these subunits, which may be located in the
cys loop, as already shown for the δ nAChR subunit
(Strecker et al., 1994). Since the cys loop is known to
be hidden in the course of the maturation pathway
(Green and Wanamaker, 1997), the concomitant hin-
drance of this high-mannose glycosylated site could
plausibly be one of the conformational signals govern-
ing escape from the ER.
We also show that the exit from the ER to medial
Golgi compartment is a relatively slow process as com-
pared to the maturation steps. Maturation, as judged
by hetero-oligomerization and mAb290 recognition, is
nearly completed after 30 min, whereas trafficking andcomplex oligosaccharide glycosylations require around
3 hr. Therefore, our kinetic data clearly show that exit
from the ER is the limiting step within the secretory
pathway, pointing to an accumulation of protein within
the ER, a feature that is commonly observed for
nAChRs expressed in cell lines (Grailhe et al., 2004), in
neurons (Nashmi et al., 2003), and in rodent brain (Ar-
royo-Jimenez et al., 1999). Accordingly, we observed an
accumulation of high-affinity binding sites in intracellu-
lar compartments (85% inside the cell and 15% at the
cell surface) and a strong colocalization of the β2 sub-
unit with the ER by immunofluorescence imaging. Sim-
ilar values for intracellular nAChR percentages were
obtained for other receptors expressed in cell lines
(Harkness and Millar, 2002; Peng et al., 1997; Whiteaker
et al., 1998).
Nicotine and Upregulating Ligands Act
as Maturational Enhancer
Our dissection offered the possibility to directly assess
the action of nicotine on the various cellular processes.
Neuron
604We demonstrate herein an action of nicotine on the
early maturation of the subunit protein, since (1) nico-
tine acts intracellularly: nicotine elicits a major increase
in the amount of high-mannose oligomers recognized
by both mAb290 and mAb299. Since these oligomers
are not found at the cell surface, these experiments de-
monstrate an intracellular action of nicotine, but also of
carbamylcholine, DHβE, and choline; (2) nicotine acts
shortly after protein synthesis: as soon as 30 min after
protein synthesis, nicotine elicits a 2-fold increase in
the amount of subunit immunoprecipitated by both an-
tibodies; furthermore, nicotine also elicits a major
change during the 45 min following the 30 min meta-
bolic labeling, by increasing by 1.5-fold the amount of
immunoprecipitation by mAb290; this indicates that,
during this period, a fraction of the subunit oligomers
are converted into species with a conformation that is
recognized by mAb290. The fitting of the dynamic data
with a simple sequential two-step model suggests that
nicotine acts on a population of subunits/oligomers not F
recognized by mAb290, which we called “nicotine sen- n
sitive precursors,” facilitating the conversion of these C
precursors into species recognized by mAb290, and o
uthat display higher metabolic stability.
MThus, the α4β2 receptor matures rather inefficiently,
ta process that is partly overcome by the action of nico-
ptine during the early steps of the intracellular matura-
i
tional processes. Nicotine therefore acts as a “matura- s
tional enhancer” (Figure 7). This mechanism is similar e
to the pharmacological rescue of G protein-coupled re- n
eceptors, initially identified for vasopressin receptor
scongenital mutations (Morello et al., 2000). It is note-
uworthy that the inefficient maturation of nAChRs is not
2
only observed in transfected cell lines, but also in na- p
tive tissues. For example, in the rat brain, the majority p
of α4 subunits are found inside the cells (Arroyo-Jime- i
nez et al., 1999). A recent paper by Christianson and
Green (Christianson and Green, 2004) also shows that
the maturation of the muscle-type nAChRs in mouse m
myotubes is inefficient, since proteasome inhibitors t
upregulate the number of high-affinity receptors at the a
cell surface by allowing the processing of subunits that t
would otherwise be degradated. Thus, inefficient matu- w
ration is not restricted to recombinant systems and W
seems to be a common property of nAChRs. f
While the maturational enhancer mechanism is p
clearly the major cause of upregulation in our experi- e
mental paradigm, the present study is not incompatible s
with other long-term effects of nicotine that were pre- b
viously reported. First, it is possible that a reduced t
turnover rate of the receptor makes a minor contribu-
tion to upregulation, as previously suggested for α3β2
Areceptors (Wang et al., 1998), but such a contribution
iwould be too weak to be monitored within the precision
Iof our experiments. Second, upregulation is associated
rwith a change in the functional properties of the recep-
ttors (Buisson and Bertrand, 2001), a feature that we
sconfirm by electrophysiological methods. It is thus pos-
tsible that nicotine also acts on functional surface re-
iceptors to displace an equilibrium between low- and
thigh-affinity states of α4β2 receptors, as previously
eproposed (Buisson and Bertrand, 2001). Still, the matu-
prational enhancer mechanism can account for such a
functional alteration, if one assumes that nicotine pro- figure 7. Mechanism of Nicotine Upregulation Inferred from Immu-
oprecipitation Experiments
artoon schematically representing the maturation and trafficking
f α4β2 receptors. After synthesis in their high-mannose form, sub-
nits mature within the ER into high-affinity pentameric receptors.
aturation involves oligomerization and folding events that allow
he recognition between the β subunit and mAb290. After these
rocesses, only pentameric receptors are allowed to traffic forward
nto the secretory pathway, through the Golgi apparatus where
ugars are trimmed and processed into complex carbohydrates, to
ventually reach the cell surface. According to our experiments,
icotine, which efficiently crosses the cell membrane, acts on the
arly maturation within the ER on an oligomeric species that pos-
ess an unknown stoichiometry αiβj. In regard to the location of the
pregulation microdomain previously identified (Sallette et al.,
004) at the α/β interface (represented by a light gray square), we
ropose that nicotine binds to a nicotine-sensitive precursor and
romotes a critical subunit-subunit interaction step that is limiting
n the maturation of the α4β2 receptor.otes a particular maturational pathway that would ul-
imately favor a different receptor state. For instance,
n increased proportion of the β subunit within func-
ional pentamers has been shown to be concomitant
ith α4β2 receptor upregulation (Nelson et al., 2003).
e do not observe significant changes in the α/β ratio
ollowing upregulation in our immunoprecipitation ex-
eriments, but since these experiments examine the
ntire population of the receptors, alteration of receptor
toichiometries within specific subpopulations cannot
e ruled out. Further studies would be required to test
hese possibilities.
Critical Role of Subunit-Subunit Interaction
n the Upregulation Process
n the absence of nicotine, the weak maturation of α4β2
eceptors is a priori related to their complex architec-
ure. This implies sequential hetero-oligomerization
teps, concomitant with folding of the extracellular and
ransmembrane domain and disulfide-bridge process-
ng (Green and Millar, 1995). Yet, previous work pointed
o a major role of subunit-subunit interaction in this in-
fficient maturation: (1) a 16 amino acid microdomain
aving the α/β interface was found to govern the dif-
erent expression and upregulation patterns of β2 and
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605β4 containing receptors (Sallette et al., 2004): α3/α4β2
receptors mature inefficiently and are strongly upregu-
lated by nicotine, whereas α3/α4β4 receptors mature
efficiently and are weakly upregulated, (2) an increased
assembly of GFP-tagged α4 and β2 subunits inside the
cells following nicotine upregulation was inferred from
fluorescence energy transfer experiments (Nashmi et
al., 2003), and (3) upregulation increased the coimmu-
noprecipitation between the Triton X-100 solubilized α3
and β2 subunits (Wang et al., 1998). Thus, the β2 sub-
unit confers weak receptor maturation due to inefficient
subunit interaction and/or assembly. This would result
in a transient population of immature species called
“nicotine-sensitive precursors,” which are rapidly de-
gradated in control conditions but rescued in the pres-
ence of nicotine. In regard to the fast kinetics of recep-
tor maturation at 37°C, it is likely that within the 30 min
of metabolic labeling these nicotine-sensitive precur-
sors represent a small fraction of the total population,
since the closely related mouse muscle-type nAChR
has been shown to assemble in less than 20 min at
37°C (Green and Claudio, 1993).
Interestingly, while the concentration required to
upregulate the receptors are 100- to 1000-fold higher
than those required to occupy the agonist binding site
at equilibrium, an excellent correlation between the
EC50 for upregulation and the KD for ligand binding was
observed by many authors in several expression sys-
tems (Gopalakrishnan et al., 1997; Warpman et al.,
1998; Whiteaker et al., 1998). These results suggest that
the binding site for upregulation corresponds to the
classical nicotine binding site that bridges the α/β sub-
unit interface, but in an immature low-affinity conforma-
tion. Therefore, we propose that oligomeric immature
entities displaying low but significant affinity for com-
petitive ligands are the target for nicotine. Nicotine
would bind to these precursors to stabilize a conforma-
tion possessing higher affinity for nicotine and facilitate
progression to further steps of maturation toward high-
affinity receptors. The particular location of the afore-
mentioned microdomain, which bridges the nicotinic
binding site and the subunit interface, suggests a mo-
lecular mechanism in which nicotine binds to the nico-
tine-sensitive precursor and stabilizes a conformation
of the microdomain, strengthening the intersubunits in-
teractions.
Conclusion
We also found that the maturational enhancer mecha-
nism investigated in transfected HEK293 cells also
takes place in transfected SH-SY5Y neuroblastoma
cells, in particular under low micromolar nicotine con-
centrations that are close to the nicotine concentra-
tions found in the blood of smokers. These latter cells
express several nAChRs and resemble human fetal
sympathetic neurons grown in primary culture. This
supports the conclusion that the maturational enhancer
mechanism contributes to nicotine upregulation in ani-
mal models and possibly in the smoker.
As discussed in previous papers (Buisson and Ber-
trand, 2002; Dani and De Biasi, 2001), upregulation may
have important consequences in the long-term effect
of nicotine, possibly including nicotine sensitization,tolerance, and/or addiction, and possibly in schizo-
phrenic disorders, since the brain of patients with
schizophrenia present much less upregulation as com-
pared to control smokers (Breese et al., 2000). The ob-
servation that upregulation produces an increase in
nicotine-elicited release of dopamine within the meso-
limbic pathway may be particularly important in addic-
tive processes.
In addition, the observation that upregulation is a con-
served feature among neuronal heteromeric nAChRs,
particularly those containing the β2 subunit, is intrigu-
ing. We previously found that the compact micro-
domain from the β2 subunit that confers both low matu-
rational efficacy and strong upregulation is highly
conserved among species, including mouse, chick, rat,
and human. This suggests that upregulation fulfills a
specific physiological role. Our observation that choline
strongly upregulates the α4β2 receptor, at concentra-
tions compatible with those measured in the rat brain
(between 10 and 20 M under normal conditions, and
to over 100 M under pathological circumstances
[Uteshev et al., 2003]) suggests that it may act as a
positive maturational effector under physiological con-
dition. In such a scheme, liberation of ACh from varico-
sities would lead to elevated levels of “ambient” ACh
and/or choline, causing upregulation of nAChRs in the
vicinity of the sites of neuromodulator liberation.
Experimental Procedures
Cell Culture, Transfection, and Upregulation
Human embryonic kidney HEK293 cells and SH-SY5Y neuro-
blastoma cells were cultured in Minimum Essential Medium con-
taining 100 units/ml penicillin, 100 g/ml streptomycin, 2 mM gluta-
mine, and 10% fetal calf serum (Invitrogen) in a 5% CO2 incubator
at 37°C. Cells were grown in 90 mm dishes and transfected with
the human α4 and β2 cDNA in the pRcCMV vector (Monteggia et
al., 1995) using the calcium-phosphate method (Sallette et al.,
2004) and were rinsed 24 hr after transfection. Upregulating ligands
were added to the culture medium 24 hr after transfection, and
experiments were performed 48 hr after transfection. In immuno-
precipitation experiments, ligands at the same concentration were
also present during the methionine deprivation, the metabolic la-
beling, and the chase periods. In binding and electrophysiological
experiments, ligand-containing medium was replaced twice by li-
gand-free medium during 1 hr before the measurements to ensure
their complete removal.
Metabolic Labeling and Immunoprecipitation
Cells were treated for 20 min in methionine- and cystine-free
DMEM (Invitrogen), labeled with 300 Ci/dish Redivue L-Pro-mix
[35S] (Amersham) and chased with methionine-containing medium.
Cells were washed three times in PBS, harvested in 5 mM EDTA in
PBS, centrifuged at 1500 rpm, solubilized overnight in 200 l/dish
ice-cold buffer A (150 mM NaCl, 50 mM Tris-Cl [pH = 8], 2 mM
N-ethylmaleimide [Sigma], 5 mM EDTA, 1% lubrol, 1.83 mM mg/
ml phosphatidylcholine [Sigma], and complete protease inhibitor
cocktail [Roche]) (Green and Claudio, 1993) and centrifuged 10 min
at 100,000 × g. Supernatant was precleared 30 min with 15 l/dish
protein G-coated dynabeads (Dynal) and incubated 24 hr at 4°C
with mAb299 or mAb290 (Sigma) or anti-GFP (Invitrogen) at 1/200
dilution. 30 l/dish dynabeads were added for 3 hr at 4°C, pelleted
by centrifugation, washed four times in buffer A containing 1, 1,
0.5, or 0.15 mM NaCl (Cooper and Millar, 1997), detached for 10 min
at 100°C using 20 l/dish red loading buffer (Biolabs) containing
0.5 mM DTT and 5 l SDS 20%. Endo-H and PNGase-F (Biolabs)
digestions were performed for 1 hr at 37°C before the addition of 5
l SDS 20%. The supernatant was loaded on a 7% Tris-Acetate
NuPage gel (Invitrogen). The gel was fixed for 1 hr, incubated for 1
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606hr in En[3H]ance (NEN), rinsed in water for 1 hr, and dried overnight S
Tat 37°C. Autoradiography was performed using Bio-Max MR films
(Kodak) whose linearity was checked with Autoradiographic w
[14C]micro-scales (Amersham). Quantification of the bands was
performed by scanning densitometry. For the parallel mAb290 and
anti-GFP immunoprecipitations, 30% and 70% of the material was A
respectively immunoprecipitated with anti-GFP and mAb290, and
both fractions were pooled before solubilization in red loading W
buffer and loading on a 10% Bis-Tris NuPage gel. r
P
b[3H]-Epibatidine Binding m
[3H]-epibatidine was incubated with intact cells (respectively solu- t
bilized receptors) for 30 min at 37°C, filtered through GF/C filters p
preincubated in 1% milk powder solution (respectively, three super-
imposed GF/C filters preincubated in 1% polyethylene imine
R[Sigma]) (Sallette et al., 2004). The filters were incubated in BCS
Rcounting scintillant (Amersham) and counted in a LKB-Wallak
Acounter.
P
Immunofluorescence Labeling R
HEK293 or SH-SY5Y cells transfected with cDNA of α4, β2, and
pECFP-Golgi Vector (Clontech) were cultured on glass coverslips A
pretreated with poly-L-lysine and fixed for 15 min with 4% formal- A
dehyde at 37°C. All subsequent steps were performed at room tem- (
perature. Cells were permeabilized for 5 min with 0.2% Triton r
X-100. Nonspecific sites were blocked for 30 min with PBS contain- N
ing 10% of goat serum. ER staining was performed according to
B
the manufacturer’s instructions (SelectFX Alexa fluor 488 Endo-
t
plasmic Reticulum Labeling kit, Molecular Probes). β2 subunit
i
staining was performed with mAb 290, dilution 1/2500 for 90 min
Band incubation with a goat anti-rat IgG coupled to Alexa Fluor 568
K(Molecular probes), dilution 1/1000, for 1 hr. After mounting cover-
rslips with Vectashield mounting medium (Vector Laboratories), fluo-
srescence was viewed under Zeiss confocal LSM 510 microscope.
B
u
Analysis of Surface Receptors t
Cells were incubated for 30 min at 4°C in PBS containing 0.5 mM B
sulfo-NHS-biotine (Uptima), rinsed in PBS and solubilized overnight s
in buffer A. After immunoprecipitation (as described above), the 1
subunits were separated on a 7% Tris-acetate NuPage gel (Invitro-
Cgen) and transferred onto a nitrocellulose membrane (Amersham).
rAfter overnight saturation in PBS containing 0.5% milk powder, 1%
2BSA, and 0.05% Tween 20, blots were incubated in 1/2000 peroxy-
Cdase-conjugated extravidine (Sigma) in the same buffer for 1 hr.
aAfter three washes, biotinylated cell surface receptors were re-
svealed by the ECL+ (Amersham) procedure as described by the
supplier. D
a
ESucrose Gradients
pMetabolically labeled cells were solubilized overnight. After pre-
Fclearing the cell lysate, the solution was loaded on an 11 ml 3%–
t30% (w/v) sucrose gradient in solubilization medium. Gradients
iwere run in a SW 41 rotor (Beckman) 26 hr at 37 000 RPM at 4°C.
n250 l to 1 ml fractions were manually collected from the top of
the gradient. Each fraction was immunoprecipitated as described G
above. For [3H]-epibatidine analyzed gradients, the same pro- E
cedure was performed on nonlabeled cells. Pentameric fraction S
was assessed by running the Torpedo receptor in parallel accord- a
ing to Nelson et al. (2003). r
G
tElectrophysiology c
Electrophysiological recordings were performed as previously de- P
scribed (Grutter et al., 2003). Briefly, macroscopic currents were
Grecorded on HEK293 cells cotransfected with the α4, β2, and green
Bfluorescent protein cDNAs, using the whole-cell patch-clamp tech-
snique, at a holding potential of −60 mV. Only transfected cells (visu-
salized with a fluorescent microscope for the presence of GFP)
Nwere tested.
Gupplemental Data
he Supplemental Data for this article can be found online at http://
ww.neuron.org/cgi/content/full/46/4/595/DC1/.
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